Validation of Thromboelastograph system (TEG®) in critically ill children admitted in the Pediatric Intensive Care Unit (PICU)

Validation of Thromboelastograph system (TEG®) in critically ill children admitted in the Pediatric Intensive Care Unit (PICU) - PIMTEG

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30976

Enrollment

Registered

2007-08-02

Start date

2007-07-01

Completion date

Unknown

Last updated

2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bloedstolling clotting study / hemostatic study

Interventions

None listed

Eligibility

Age

2 Years to 11 Years

Inclusion criteria

Inclusion criteria: •Arterial or central venous line in situ. Insertion of arterial or venous line must be indicated on clinical basis as a part of normal critical care management. No lines will be inserted just for study purposes. •Written informed consent

Exclusion criteria

Exclusion criteria: •Dysfunctional arterial or central venous line - no free flowing sampling of blood possible

Design outcomes

Primary

Measure	Time frame
Establishing intra- and inter observer variability of TEG® parameters (clotting time (r), clot kinetics (k and alfa angle) and clot strength (maximum amplitude)) in 0,5 ml kaolin activated whole blood of critically ill children.	—

Secondary

Measure	Time frame
Determination of TEG® manipulation duration and time to results of the different TEG® parameters.	—

Countries

Netherlands

Outcome results